why would any capable exec take on this basket case?
hope she has the connections for to get some deals done but seems a bit light in any licensing expertises or clinical trials or regulatory or manufacturing . Maybe the Tony Eglezes and Jeremy Paul can show her how not to do that.
I look forward to a good house clean in January of the deadwood jackyophiles that have milked the weak board.
SPL Price at posting:
14.0¢ Sentiment: None Disclosure: Held
